Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
137.00    -8.00 (-5.52%)
Bid:
137.00
Ask:
140.00
Spread: 3.00 (2.19%)
Market Cap: £107.51m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

19 Jan 2012 07:00

RNS Number : 8017V
Xaar PLC
19 January 2012
 



 

 

 

FOR IMMEDIATE RELEASE

19 January 2012

 

 

 

Xaar plc

 

 

YEAR END TRADING UPDATE

 

 

Xaar plc ("Xaar" or "the Group" or "the Company"), the inkjet printing technology group headquartered in Cambridge, announces an update on trading for the year ended 31 December 2011.

 

Trading for the fourth quarter of the year was slightly ahead of the Board's expectations, leading to a strong performance for the full year 2011.

 

Xaar expects to announce revenue of approximately £69 million for 2011, an increase of over 25% compared to 2010 (£54.7 million).

 

Revenue growth in 2011 was achieved mainly by increased sales into the industrial segment. Demand for Xaar's technology in this segment is principally driven by the conversion of ceramic tile printing to digital inkjet from analogue processes. During the year, Xaar made good progress with the capacity expansion programme to support this demand and the programme remains on track to continue to deliver the planned incremental capacity during the first half of 2012.

 

As expected, product sales into the graphic arts segment declined in 2011 by approximately 15% compared to 2010. As previously described, this decline reflects market maturity and competitive pressure.

 

The Group continues to maintain a strong balance sheet with net cash at 31 December 2011 of £17.4 million (30 June 2011 - £20.6 million; 31 December 2010 - £22.0 million).

 

The detailed results for 2011 are expected to be announced on 20 March 2012.

 

Board changes

 

As previously announced Phil Eaves, Sales and Marketing Director, informed the Company in 2011 of his intention to retire from full time employment in June 2012. Following an extensive search process, the Company is pleased to announce that Richard Barham has been appointed Sales and Marketing Director and member of the Xaar board with effect from 5 March 2012. After completion of a handover period, Phil Eaves will continue to support the Company in a consultant role until 30 June 2012.

 

Ian Dinwoodie, Chief Executive commented:

 

'On behalf of everyone at Xaar, I would like to thank Phil for his efforts and contribution over the last 7 years during which our revenues have grown significantly. We all wish him well for the future.

 

I am pleased to welcome Richard to the Board, who brings a wealth of experience gained through 25 years spent in numerous sectors of the Imaging and Printing industries.'

Since 1986, Mr Barham has held a range of sales, marketing and management positions at Agfa Graphics NV, where most recently, since February 2008, he acted as Vice President of the Inkjet Division where he was responsible for turning the business around and integrating a major acquisition.

 

There is no further information concerning Mr Barham which requires disclosure under rule 9.6.13 of the UK Listing Authority Listing Rules.

 

 

END

 

CONTACTS

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Alex Bevis, Finance Director

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Simon Bloomfield

020-7367-8888 / 07771-758517

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDVLFFLFFFBBB
Date   Source Headline
6th Aug 20108:55 amRNSHolding(s) in Company
6th Aug 20108:50 amRNSHolding(s) in Company
4th Aug 20103:33 pmRNSNotice of Half Yearly Report
20th Jul 20107:00 amRNSTrading Statement
23rd Jun 20109:18 amRNSHolding(s) in Company
23rd Jun 20109:17 amRNSHolding(s) in Company
22nd Jun 20103:38 pmRNSHolding(s) in Company
14th Jun 20103:06 pmRNSHolding(s) in Company
10th Jun 20102:15 pmRNSHolding(s) in Company
7th Jun 20109:00 amRNSHolding(s) in Company
4th Jun 20101:54 pmRNSHolding(s) in Company
3rd Jun 20104:47 pmRNSHolding(s) in Company
20th May 201011:03 amRNSResult of AGM
20th May 201010:25 amRNSHolding(s) in Company
18th May 20105:44 pmRNSHolding(s) in Company
18th May 20102:13 pmRNSHolding(s) in Company
26th Apr 201011:51 amRNSHolding(s) in Company
22nd Apr 20109:28 amRNSHolding(s) in Company
19th Apr 20107:00 amRNSInterim Management Statement
17th Mar 20107:00 amRNSFinal Results
12th Mar 20109:00 amRNSHolding(s) in Company
4th Mar 20107:00 amRNSDirectorate Change
1st Mar 20107:00 amRNSNotice of Final Results
19th Feb 20109:00 amRNSHolding(s) in Company
21st Jan 20107:00 amRNSPeriod end trading update
26th Oct 200910:42 amRNSHolding(s) in Company
14th Oct 20097:00 amRNSInterim Management Statement
16th Sep 20093:19 pmRNSHolding(s) in Company
10th Sep 200911:18 amRNSHolding(s) in Company
2nd Sep 20099:59 amRNSHolding(s) in Company
19th Aug 20097:00 amRNSHalf Yearly Report & Results
11th Aug 20097:00 amRNSNotice of Half Yearly Report
15th Jul 20097:00 amRNSHalf year period-end trading update
5th Jun 20091:22 pmRNSHolding(s) in Company
2nd Jun 200911:26 amRNSHolding(s) in Company
2nd Jun 200911:24 amRNSHolding(s) in Company
5th May 20095:04 pmRNSHolding(s) in Company
29th Apr 20092:06 pmRNSResult of AGM
16th Apr 20093:23 pmRNSGrant of Options
16th Apr 20097:00 amRNSAnnual Information Update
16th Apr 20097:00 amRNSInterim Management Statement
8th Apr 20099:35 amRNSChange of Adviser
7th Apr 20094:47 pmRNSDirector/PDMR Shareholding
3rd Apr 20093:38 pmRNSDirector/PDMR Shareholding
1st Apr 20094:04 pmRNSDirector/PDMR Shareholding
1st Apr 20097:00 amRNSManufacturing rationalisation
26th Mar 20095:21 pmRNSDirector/PDMR Shareholding
25th Mar 200910:38 amRNSDirector/PDMR Shareholding
23rd Mar 20097:00 amRNSFinal Results
13th Mar 20094:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.